Navigation Links
Complete ANX-530 Safety Data to be Published in the 2008 Proceedings of the American Society of Clinical Oncology
Date:3/10/2008

SAN DIEGO, March 10 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: ANX) announced today that complete safety data from its registrational bioequivalence clinical study of ANX-530 (vinorelbine emulsion) will be published in the 2008 Proceedings of the American Society of Clinical Oncology (ASCO) in connection with ASCO's 2008 Annual Meeting, which takes place May 30 - June 3, 2008 in Chicago, IL. The abstract, entitled "Tolerability and incidence of infusion site reactions with emulsion formulation of vinorelbine (ANX-530) compared to vinorelbine solution," will be published.

ADVENTRX recently completed a registrational bioequivalence clinical study of ANX-530. Pharmacokinetic equivalence, the primary endpoint of the study, was observed between ANX-530 and Navelbine(R). Furthermore, in post hoc analyses, ANX-530 demonstrated a statistically significant reduction in injection site reactions when compared to Navelbine. ADVENTRX intends to submit to the U.S. Food and Drug Administration (FDA) in the fourth quarter of 2008 a Section 505(b)(2) NDA for ANX-530.

About ANX-530 (vinorelbine emulsion)

ANX-530 is a novel emulsion formulation of the chemotherapy drug vinorelbine. Navelbine, a branded formulation of vinorelbine, is approved in the U.S. to treat advanced non-small cell lung cancer as a single agent or in combination with cisplatin, and approved in the European Union to treat non-small cell lung cancer and advanced or metastatic breast cancer. Worldwide sales of Navelbine and generic formulations of vinorelbine in 2006 were in excess of $200 million.

Navelbine and its generic equivalents are often associated with injection site reactions, including phlebitis, erythema and pain at the site of in
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008
2. CHOP-Zevalin(R) Investigational Regimen Produces 95% Complete Remission and 75% Estimated Two Year Progression-Free Survival in Elderly Patients with Diffuse Large B-cell Lymphoma
3. D-Pharm Completes Pre-IND Meeting With the FDA for Treatment of Acute Stroke With DP-b99
4. Plurality Completes R&D of its HAL-256 Multicore Processor
5. First Complete Career Service for Life-Science Professionals
6. Cadence Pharmaceuticals Completes $49.3 Million Registered Direct Offering
7. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
8. Inverness Medical Innovations Completes Acquisition of BBI Holdings Plc
9. Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization
10. Alynx, Co. Completes Merger With Medical Device Company MiMedx, Inc.
11. ADVENTRX to Present Complete ANX-530 Pharmacokinetic Data at the 2008 American Association for Cancer Research Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... Switzerland’s MS Tûranor PlanetSolar , the ... record for a transatlantic crossing by a solar electric ... 25, 2013, the solar powered boat sailed 2,867miles (5,310 ... of 5.3 knots before reaching Marigot, St. Martin, in ... first-of-its-kind catamaran completed this year’s passage across the Atlantic ...
(Date:5/17/2013)... 17, 2013 Oven Industries Inc. announces ... 5R6-900 temperature controller has many user-friendly benefits. Contained all ... the wall as a self-contained temperature control ... detail makes the device unique, as well as highly ... also be used universally, which allows the user to ...
(Date:5/17/2013)... Cardiff, UK (PRWEB) May 17, 2013 ... by Photonics21 at the association’s recent annual ... others including EC Vice-President Neelie Kroes, who called the ... between sectors, and a stimulant to European innovation.” , ... the structure of the new Photonics PPP at its ...
(Date:5/17/2013)... 17, 2013  Yongye International, Inc. (NASDAQ: ... manufacturer, and distributor of crop nutrient products in ... announced that, on May 16, 2013, the special committee ... "Board of Directors") was provided a letter (the "Letter") ... ) Limited ("Abax") to Full Alliance International Limited ...
Breaking Biology Technology:MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 2MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 3MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 4MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 5MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 6New Temperature Control Products Announced by Oven Industries Inc. 2SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 2SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 3Yongye International Provides Update on Status of Proposed Go Private Offer 2Yongye International Provides Update on Status of Proposed Go Private Offer 3Yongye International Provides Update on Status of Proposed Go Private Offer 4
... ... with regulatory agencies in Latin America regarding approvals of Stemedica’s allogeneic adult stem cell products ... the United States. , ... (PRWEB) June 24, 2010 -- Stemedica Cell Technologies, Inc., a leader in ...
... Spain , June 24 Spanish biotechnology company ... has granted Grifols exclusive world-wide distribution rights for its BLOODCHIP® ... blood donors to assure the compatibility of blood for transfusion ... , , ...
... Vt ., June 22 As previously announced on October ... of the Del-ID system to an Ontario company, QTECH SYSTEMS INC. ... announce leadership changes and appointments to QTECH,s Management Team and the appointment of ... . , , , ...
Cached Biology Technology:Stemedica Announces the Appointment of Dr. Csar Amescua Garcia as Medical and Regulatory Affairs Director – Latin America 2Progenika Biopharma Grants Grifols World-Wide Distribution Rights for the BLOODCHIP® Genotyping Test for Blood Donors 2Progenika Biopharma Grants Grifols World-Wide Distribution Rights for the BLOODCHIP® Genotyping Test for Blood Donors 3delSECUR CORPORATION Announces Organizational Update as QTECH SYSTEMS INC. Expands Leadership Team 2delSECUR CORPORATION Announces Organizational Update as QTECH SYSTEMS INC. Expands Leadership Team 3
(Date:5/17/2013)... of a group of proteins in the brain responsible ... new target that could increase cell survival. , The ... Biochemistry and published in the EMBO journal ... to new therapies for stroke and other brain diseases. ... team which identified a protein, known as SUMO, responsible ...
(Date:5/17/2013)... human-caused climate change may have little impact on ... of recent studies that predict their widespread extinction ... which appear in the journal Global Change ... a creature thought to be doomed: http://onlinelibrary.wiley.com/doi/10.1111/gcb.12253/abstract ... especially forest lizards, will be hard hit by ...
(Date:5/16/2013)... 2013) Illustrating a commitment to the support ... Association (AGA) Research Foundation has announced the inaugural ... Award recipients. Supported by the National Institute of ... new award helps underrepresented minority students to further ... research. , "By establishing this new award, AGA ...
Breaking Biology News(10 mins):SUMO wrestling cells reveal new protective mechanism target for stroke 2Climate change may have little impact on tropical lizards 2Underrepresented minority students receive fellowships in digestive disease and nutrition research 2
... and center of today,s political debates, the other indicators of ... in the public conscience. Featured as part of the ... newsstands today, U of M professor Jon Foley makes the ... all environmental processes that contribute to the Earth,s health. In ...
... University] Protein phosphorylation is a process by ... to another. It is a crucial function for ... cellular process, including metabolism, gene transcription, cell-cycle progression, ... its importance in biology, scientists have wanted to ...
... team of researchers, led by a UC Davis veterinary endocrinologist, ... in rats that is similar to bariatric surgery in humans ... also have identified biochemical changes caused by the surgeries that ... study, published online in the journal Gastroenterology , should ...
Cached Biology News:Key enzyme discovered to be master regulator in protein-protein reactions 2New study may explain how weight-loss surgery reverses type 2 diabetes 2New study may explain how weight-loss surgery reverses type 2 diabetes 3New study may explain how weight-loss surgery reverses type 2 diabetes 4
WD-repeat protein 4...
Rabbit polyclonal to MDM2 (phospho S185) ( Abpromise for all tested applications). entrezGeneID: 4193 SwissProtID: Q00987...
... Cultured human omental preadipocytes ... but otherwise healthy donors. ... of diabetic cells. Please ... Support media also available. ...
ASCIZ...
Biology Products: